Search

In-depth analysis of the potential upcoming sickle cell gene therapy launches with ICER's president
Steve Pearson walks us through the potential demand and accessibility dynamics of these key gene therapy launches.
Jul 28, 2023


ICER’s newly-named president elect on drug pricing and ICER’s future
Sarah Emond was named president-elect of ICER. She explains her view of ICER’s role and where she sees drug pricing headed in the future.
Jun 29, 2023